MedTrace Logo

Heparin or Enoxaparin in Patients With Cancer

NCT00004875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2011-02-21

No results posted yet for this study

Summary

RATIONALE: Heparin or enoxaparin may be effective in preventing the formation of blood clots in patients with cancer who are undergoing surgery to remove the tumor.

PURPOSE: Randomized clinical trial to compare the effectiveness of heparin with that of enoxaparin in patients who have cancer.

Conditions

  • Lymphoma
  • Thromboembolism
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

enoxaparin

DRUG

heparin

Sponsors & Collaborators

Principal Investigators

  • Hau C. Kwaan, MD · Veterans Affairs Medical Center - Lakeside Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-07-31
Primary Completion
1999-03-31
Completion
1999-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004875 on ClinicalTrials.gov